These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23451607)

  • 1. [What's new in multiple sclerosis therapy?].
    Vaney C; Derfuss T
    Rev Med Suisse; 2013 Jan; 9(371):285-7. PubMed ID: 23451607
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry
    Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment modification in multiple sclerosis: classifications, alternatives, and the outcomes].
    Cendrowski W
    Neurol Neurochir Pol; 2007; 41(4):365-8. PubMed ID: 18027457
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic cerebrospinal venous insufficiency.
    Antel J; Thompson A; Carroll W
    Mult Scler; 2010 Jul; 16(7):770. PubMed ID: 20621949
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives.
    Zivadinov R; Ramanathan M; Dolic K; Marr K; Karmon Y; Siddiqui AH; Benedict RH; Weinstock-Guttman B
    Expert Rev Neurother; 2011 Sep; 11(9):1277-94. PubMed ID: 21864074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A swan song for CCSVI.
    Reekers J
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):287-8. PubMed ID: 24402646
    [No Abstract]   [Full Text] [Related]  

  • 7. Endovascular venous procedures for multiple sclerosis?
    Cortes Nino Mdel P; Tampieri D; Melançon D
    Mult Scler; 2010 Jul; 16(7):771-2. PubMed ID: 20621950
    [No Abstract]   [Full Text] [Related]  

  • 8. [Review of the therapy of multiple sclerosis].
    De Rosa A; Puccini A; De Martino V
    Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple sclerosis: where will we be in 2020?
    Miller AE
    Mt Sinai J Med; 2011; 78(2):268-79. PubMed ID: 21425270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease modification in multiple sclerosis.
    Sheerani M
    J Pak Med Assoc; 2003 Dec; 53(12):612-5. PubMed ID: 14765944
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosis.
    Achiron A; Miron S; Shoenfeld Y
    Isr Med Assoc J; 2005 May; 7(5):283-5. PubMed ID: 15909458
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS.
    Pöllmann W; Erasmus LP; Feneberg W; Straube A
    Neurology; 2006 Jan; 66(2):275-7. PubMed ID: 16434675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of multiple sclerosis.
    Rudick RA; Cohen JA; Weinstock-Guttman B; Kinkel RP; Ransohoff RM
    N Engl J Med; 1997 Nov; 337(22):1604-11. PubMed ID: 9371858
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic cerebrospinal venous insufficiency and multiple sclerosis.
    Bagert BA; Marder E; Stüve O
    Arch Neurol; 2011 Nov; 68(11):1379-84. PubMed ID: 21747006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new era of multiple sclerosis therapy.
    Olsson T
    J Intern Med; 2014 Apr; 275(4):382-6. PubMed ID: 24433367
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal venous insufficiency and multiple sclerosis: investigating the truth.
    Khan O
    Mult Scler; 2011 May; 17(5):511-2. PubMed ID: 21632698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current methods of the multiple sclerosis treatment].
    Kovalenko PA; Shamanskiĭ SV; Baziĭ NI
    Voen Med Zh; 2001 Oct; 322(10):45-52. PubMed ID: 11764483
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis.
    Rudick RA
    J Neuroimaging; 2004 Jul; 14(3 Suppl):54S-64S. PubMed ID: 15228760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and MRI effects of Glatirameracetate].
    Nervenarzt; 1999 Aug; 70(8 Suppl):1-8. PubMed ID: 10511871
    [No Abstract]   [Full Text] [Related]  

  • 20. Glatiramer: a second look. With longer follow-up: still no proven benefit in multiple sclerosis.
    Prescrire Int; 2009 Dec; 18(104):252. PubMed ID: 20025092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.